Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10184009 Mutant interleukin-2 polypeptides

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 20, 2017
0
Date of Patent
January 22, 2019
0
Patent Application Number
15849501
0
Patent Citations Received
‌
US Patent 11466068 Targeted immunotolerance
0
‌
US Patent 10961310 Targeted immunotolerance
‌
US Patent 11053293 Compositions and methods for targeted cytokine delivery
‌
US Patent 11608376 Tumor-targeted agonistic CD28 antigen binding molecules
0
‌
US Patent 11642417 Compositions of protein complexes and methods of use thereof
0
‌
US Patent 11713342 Compositions and methods for targeted cytokine delivery
0
‌
US Patent 11779632 IL-2 muteins and uses thereof
‌
US Patent 11365232 Interleukin-2 fusion proteins and uses thereof
‌
US Patent 11866476 Masked IL-2-Fc fusion polypeptides
0
‌
US Patent 11945852 IL-2 muteins and uses thereof
0
•••
Patent Inventor Names
Anne Freimoser-Grundschober
0
Sylvia Herter
0
Thomas U. Hofer
0
Valeria G. Nicolini
0
Christian Klein
0
Ekkehard Moessner
0
Oliver Ast
0
Pablo Umana
0
Peter Bruenker
0
Ralf Hosse
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10184009
0
Patent Primary Examiner
‌
Xiaozhen Xie
0

Find more entities like US Patent 10184009 Mutant interleukin-2 polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.